Home - Products - GPCR/G Protein - Calcium Channel - Ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate

Ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate

CAS No. 99429-64-8

Ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate( —— )

Catalog No. M37010 CAS No. 99429-64-8

ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate inhibits NAD(P)H: quinone oxidoreductase 1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 172 In Stock
10MG 254 In Stock
25MG 392 In Stock
50MG 531 In Stock
100MG 710 In Stock
200MG 958 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate
  • Note
    Research use only, not for human use.
  • Brief Description
    ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate inhibits NAD(P)H: quinone oxidoreductase 1.
  • Description
    ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate inhibits NAD(P)H: quinone oxidoreductase 1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    99429-64-8
  • Formula Weight
    251.67
  • Molecular Formula
    C12H10ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOC(=O)C1=C(Cl)C2=CC=CC=C2NC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Norverapamil hydroch...

    A calcium channel blocker and the main active metabolite of verapamil.

  • CP-060

    CP-060 is a potent Ca2+ antagonist and inhibits Ca2+ overload with antioxidant and cardioprotective activities.

  • Ca2+ channel agonist...

    Ca2+ channel agonist 1 is an agonist of N-type Ca2+ channel and an inhibitor of Cdk2 (EC50s: 14.23 μM and 3.34 μM) and is used as a potential treatment for motor nerve terminal dysfunction.